PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-09 (4)

Date Title Company
09-Dec-2022 Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy Businesswire